Weight Loss3 min read

Ozempic vs Wegovy: UK Patient Information (2026)

Ozempic and Wegovy both contain semaglutide but are licensed for different indications. UK patient information. No prescription-medicine prices.

TreatCompare Editorial Team · Healthcare Price Research

Published 12 May 2026Updated 12 May 2026

Important information for UK consumers. Ozempic (semaglutide) and Wegovy (semaglutide 2.4mg) are prescription-only medicines (POMs) in the UK. UK regulations restrict the advertising of prescription medicines to the public, so this article is general patient information — it is not an advertisement, not an offer of sale, and not medical advice. This article does not display UK prices.

At a glance

Aspect	Ozempic	Wegovy
Active ingredient	Semaglutide	Semaglutide
Manufacturer	Novo Nordisk	Novo Nordisk
UK indication	Type 2 diabetes	Weight management
Maximum dose	1mg weekly	2.4mg weekly
Class	GLP-1 receptor agonist	GLP-1 receptor agonist

Why they are not interchangeable

Although both products contain semaglutide, they are licensed for different indications at different doses. Off-label use of Ozempic for weight management is a clinical decision for a UK-registered prescriber and is not endorsed by the manufacturer or the MHRA. NHS England does not commission Ozempic for weight management.

What to discuss with a UK prescriber

Whether type 2 diabetes management or weight management is the relevant clinical question.
Which licensed product is appropriate for your circumstances.
Whether NHS-funded treatment is realistic under current commissioning rules.
The dose escalation schedule and follow-up review schedule.

For full patient information see Ozempic UK patient information and Wegovy UK patient information.

If you have spotted an error

Please tell us via the corrections route.

Important context

Healthcare prices can change without notice and may exclude consultation fees, medication, diagnostics, anaesthetic, facility fees, follow-up care or add-ons. TreatCompare summarises published or compiled pricing for comparison and planning only. Always verify the current total directly before paying.

Source type: TreatCompare compiled research
Primary source: Provider-published information and TreatCompare research
Reporting period: 2026-05-12
Last updated: 2026-05-12
Figure type: Mixed sources
Use: Research and comparison only

Are you a clinic, provider or data owner?

If you believe information on this page is inaccurate, out of date, incomplete or presented without necessary context, contact us with the page URL and supporting evidence. We review correction requests promptly, but they are not automatically accepted.

Request a correction View methodology

Data funnel

Help improve UK healthcare price data

TreatCompare gets more useful when readers send real quotes, providers verify listings, and outdated claims are corrected. Submissions are reviewed before publication.

I represent a provider

Update a listing, package fee, source URL, registration detail or location.

Update provider data ->

Something looks wrong

Flag an incorrect price, outdated source, missing inclusion or disputed claim.

Report a data issue ->

Frequently asked questions

What is the difference between Ozempic and Wegovy?

Both contain semaglutide and are manufactured by Novo Nordisk. Ozempic is licensed in the UK for the management of type 2 diabetes at doses up to 1mg weekly. Wegovy is licensed for weight management at doses up to 2.4mg weekly. They are different products with different indications.

Why does this comparison not show prices?

Both are prescription-only medicines (POMs) in the UK. UK Human Medicines Regulations 2012 prohibit advertising POMs to the public, including price comparisons. TreatCompare does not display UK Ozempic or Wegovy prices.